Natalie Berner

Director/Board Member at BIOINVENT INTERNATIONAL AB

36 year

Health Technology

Consumer Services

Finance

Profile

Ms. Natalie Berner is an Independent Director at Hansa Biopharma AB, an Independent Director at BioInvent International AB and a Managing Director at Redmile Group LLC.
She is on the Board of Directors at Hansa Biopharma AB, BioInvent International AB, Redx Pharma Ltd. and Sensorion SA. Ms. Berner was previously employed as a Research Associate by New York University School of Medicine.
She received her undergraduate degree from Brown University.

Natalie Berner active positions

Companies	Position	Start
BIOINVENT INTERNATIONAL AB	Director/Board Member	2022-07-11
REDX PHARMA LIMITED	Director/Board Member	2021-05-17
SENSORION	Director/Board Member	-
HANSA BIOPHARMA AB	Director/Board Member	2025-09-01
Redmile Group LLC Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.	Portfolio Manager-Equities	2018-07-31

All active positions of Natalie Berner

Former positions of Natalie Berner

Companies	Position	End
New York University School of Medicine New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Natalie Berner's experience

Education of Natalie Berner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Natalie Berner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioInvent International AB BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment	Health Technology
Redmile Group LLC Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.	Finance
Hansa Biopharma AB Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory	Health Technology
Sensorion SA Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders	Health Technology
Redx Pharma Plc Redx Pharma Plc BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing novel, small molecule and targeted medicines for fibrotic disease	Health Technology
New York University School of Medicine New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services